Summary & Overview
HCPCS G2094: Documentation of Declined ACE Inhibitor/ARB/ARNI Therapy
HCPCS Level II code G2094 captures clinician documentation that a patient declined or otherwise had a reason for not receiving ACE inhibitor, ARB, or ARNI therapy. The code matters nationally because it records patient preference and clinical decision-making for guideline-recommended cardiovascular therapies, informing quality measurement, performance reporting, and claims-based audits. Clear use of this code helps distinguish appropriate non-prescribing from lapses in care.
Key payers included in coverage discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find national context on why documentation codes such as G2094 are used, what types of services and settings generate the code, and how it is applied in clinical workflows. The publication summarizes benchmarking and policy implications relevant to claims processing and quality programs, highlights common billing modifiers and administrative considerations (where provided), and outlines the clinical context in which the code is typically reported.
This summary is intended for billing professionals, compliance officers, and clinical leaders seeking a concise reference on the code’s purpose, typical use cases, and implications for national reporting and payment processes.
Billing Code Overview
HCPCS Level II code G2094 documents the patient's reason(s) for not prescribing ACE inhibitor, ARB, or ARNI therapy, for example when a patient declines treatment or cites other personal reasons. This code is used to record clinician documentation that a guideline-recommended medication class was considered but not initiated due to patient choice or patient-specific circumstances.
-
Service type: Documentation of clinical decision-making and counselling regarding heart failure or related indications where ACE inhibitor/ARB/ARNI therapy would be considered
-
Typical site of service: Outpatient clinic, physician office, or other ambulatory care settings where medication decisions and counseling are documented
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult with heart failure with reduced ejection fraction (HFrEF) or hypertension for whom guideline-directed therapy includes an angiotensin-converting enzyme inhibitor (ACE inhibitor), angiotensin receptor blocker (ARB), or angiotensin receptor-neprilysin inhibitor (ARNI). During an outpatient cardiology or primary care visit the clinician documents that ACE inhibitor/ARB/ARNI therapy is not prescribed and records the patient’s reason(s) for not initiating or continuing therapy (for example, patient declined due to side-effect concerns, prior angioedema, pregnancy or desire for pregnancy, current hyperkalemia, renal dysfunction, hypotension, drug intolerance, or concurrent medication interactions).
The clinical workflow: the provider reviews the patient’s history, current medications, blood pressure, renal function, and potassium; discusses risks and benefits of ACE inhibitor/ARB/ARNI therapy; offers alternatives; and documents the specific patient reason(s) for withholding therapy in the medical record. This documentation supports quality reporting and billing for code G2094. Typical sites of service include outpatient primary care clinics, cardiology clinics, and transitional care visits following hospitalization. Common patient interactions include in-person visits, telehealth visits where medication decisions are made, or medication reconciliation encounters where a patient refuses or cannot tolerate the medication class.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|